Skip to Main Content
Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to promenade with the official mascot, catch up on our reading, tidy around the castle, and take a nap or three. And what about you? This remains a fine time to enjoy the great outdoors — think of the varied leaf colors. You could also boost the economy and order a few holiday gifts. Or convince some of the holdouts to get vaccinated. Well, whatever you do, have a grand time, but be safe. Enjoy, and see you soon. …

Johnson & Johnson (JNJ) plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating how health care has changed since the company helped pioneer the industry, The Wall Street Journal reports. The move, which will occur in 18 to 24 months, will separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies. What form the separation will take, what the new company will be called, and who will lead it are yet to be worked out.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment